¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ENO"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
enostosis A mass of proliferating bone tissue within a bone.
Origin: G. En, in, + osteon, bone, + -osis, condition
(05 Mar 2000)
enough 1. In a degree or quantity that satisfies; to satisfaction; sufficiently.
2. Fully; quite; used to express slight augmentation of the positive degree, and sometimes equivalent to very; as, he is ready enough to embrace the offer. "I know you well enough; you are Signior Antonio." (Shak) "Thou knowest well enough . . . That this is no time to lend money." (Shak)
3. In a tolerable degree; used to express mere acceptableness or acquiescence, and implying a degree or quantity rather less than is desired; as, the song was well enough.
Enough usually follows the word it modifies.
Source: Websters Dictionary
(01 Mar 1998)
enoxacin <chemical> 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine 3-carboxylic acid. An orally administered broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. Its clinical efficacy has been confirmed in a variety of systemic infections and particularly in urinary tract infections. The drug is well tolerated by adults, but should not be used in children and pregnant women.
Pharmacological action: anti-infective agents, fluoroquinolone.
Chemical name: 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
(12 Dec 1998)
enoxaparin A low-molecular-weight version of heparin which acts like heparin as an anticoagulant (anti-clotting) medication. Enoxaparin is used to prevent thromboembolic complications (clots that travel from their site of origin through the blood stream to clog up another vessel). Enoxaparin is also used in the early treatment of blood clots in the lungs (pulmonary embolisms).
(12 Dec 1998)
enoximone <chemical> 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2h-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
Pharmacological action: cardiotonic agent, phosphodiesterase inhibitors, vasodilator agents.
Chemical name: 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-
(12 Dec 1998)
enoyl The acyl radical of an unsaturated aliphatic acid.
Origin: -ene + -oyl
(05 Mar 2000)
enoyl hydrase <enzyme> An enzyme that catalyses reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA.
Chemical name: (3S)-3-Hydroxyacyl-CoA hydro-lyase
Registry number: EC 4.2.1.17
(12 Dec 1998)
enoyl-ACP reductase 1. An enzyme catalyzing hydrogenation of acyl-ACP complexes to 2,3-dehydroacyl-ACP's, with NAD+ as hydrogen acceptor; important in fatty acid metabolism.
Synonym: crotonyl-ACP reductase.
2. A variant enzyme has been found carrying out the same reaction as enoyl-ACP reductase, but with NADP+ as hydrogen acceptor.
Synonym: acyl-ACP dehydrogenase, acyl-ACP reductase.
(05 Mar 2000)
enoyl-CoA hydratase <enzyme> An enzyme that catalyses reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA.
Chemical name: (3S)-3-Hydroxyacyl-CoA hydro-lyase
Registry number: EC 4.2.1.17
(12 Dec 1998)
enoyl-CoA hydratase - 3-hydroxyacyl-CoA dehydrogenase - dodecanoyl-coenzyme A delta-isomerase <chemical> Catalyses the second and third reactions of the fatty acid beta-oxidation cycle, converting enoyl-CoA to 3-ketoacyl-CoA; EC 4.2.1.17 and EC 1.1.1.35 and EC 5.3.3.8; consider also multifunctional protein-a
Synonym: peroxisomal bifunctional enzyme, enoyl-coenzyme a hydratase -- 3-hydroxyacyl-coenzyme a dehydrogenase, peroxisomal trifunctional enzyme, delta(3), delta(2)-enoyl-CoA isomerase--2-enoyl-CoA hydratase--3-hydroxyacyl-CoA dehydrogenase
(26 Jun 1999)
enoyl-CoA reductase acyl-CoA dehydrogenase (NADPH+)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 4 ÆäÀÌÁö: 2
  • Enoximone - »õâ 1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
    Synonyms : Fenoximone, MDL 19438, MDL-17, 043, MDL-17043, MDL-19, 438, Perfan, 19438, MDL, MDL 17, 043, MDL 17043, MDL 19, 438, MDL17, 043, MDL17043, MDL19, 438
  • Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific) - »õâ An enzyme that catalyzes the oxidation of acyl-[acyl-carrier protein] to trans-2,3-dehydroacyl-[acyl-carrier protein] in the fatty acid biosynthesis pathway. It has a preference for acyl derivatives with carbon chain length from 4 to 16.
    Synonyms : Acyl-ACP Dehydrogenase, Enoyl-(Acyl-Carrier-Protein)reductase (NADPH), Acyl ACP Dehydrogenase, Dehydrogenase, Acyl-ACP
  • Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - »õâ An NAD-dependent enzyme that catalyzes the oxidation of acyl-[acyl-carrier protein] to trans-2,3-dehydroacyl-[acyl-carrier protein]. It has a preference for acyl groups with a carbon chain length between 4 to 16.
    Synonyms : Enoyl(Acyl-Carrier-Protein) Reductase (NADH), NADH-Dependent Enoyl-ACP Reductase, NADH-Enoyl ACP Reductase, ACP Reductase, NADH-Enoyl, Enoyl-ACP Reductase, NADH-Dependent, NADH Dependent Enoyl ACP Reductase, NADH Enoyl ACP Reductase, Reductase, NADH-Enoyl ACP
  • Enoyl-CoA Hydratase - »õâ An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17.
    Synonyms : Enoyl CoA Hydratases, beta-Hydroxyacyl-CoA Dehydrases, trans-2-Enoyl-Coenzyme A Hydratase, 3 Hydroxyacyl CoA Hydrolyases, 3 Hydroxyacyl Dehydratases, A Hydratase, trans-2-Enoyl-Coenzyme, CoA Hydratases, Enoyl, CoA Hydrolyases, 3-Hydroxyacyl, Hydrase, Enoyl
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿¡Æ÷À̵òÁ¤100mg - »õâ
½ì¶óÆ®ÆÊÄÚ¸®¾Æ
A23402011 Enoxacin
Àü¹®ÀǾàǰ | »èÁ¦
¿¡Æ÷À̵òÁ¤200mg - »õâ
½ì¶óÆ®ÆÊÄÚ¸®¾Æ
A23402021 Enoxacin
Àü¹®ÀǾàǰ | »èÁ¦
¿¡·Ï½ÅÁ¤100mg - »õâ
À¯¿µÁ¦¾à
A34002221 Enoxacin
Àü¹®ÀǾàǰ | ºñ±Þ¿©
¿¡·Ï½ÅÁ¤200mg - »õâ
À¯¿µÁ¦¾à
A34002211 Enoxacin
Àü¹®ÀǾàǰ | ºñ±Þ¿©
¿¡³ì½ÅÁ¤ - »õâ
Çѱ¹À¯´Ï¿ÂÁ¦¾à
A12253311 Enoxacin
Àü¹®ÀǾàǰ | »èÁ¦
¿¡³ë·ÐÁÖ - »õâ
ÀÌ¿¬Á¦¾à
A01402181 Enocitabine
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
Å©·º»êÁÖ100mg - »õâ
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ
E06400485 Enoxaparin Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
Å©·º»êÁÖ20mg - »õâ
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ
E06400481 Enoxaparin Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
Å©·º»êÁÖ40mg - »õâ
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ
E06400482 Enoxaparin Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
Å©·º»êÁÖ60mg - »õâ
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ
E06400483 Enoxaparin Sodium
Àü¹®ÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
enophthalmos The sinking of the eye into the socket. Causes include development problems in utero, trauma and inflammation.
Ãâó: www.allaboutvision.com/resources/glossary.htm
enology [ee-NAHL-uh-jee] Also spelled oenology, this is the science or study of viniculture (making wines). One who studies the science is called an enologist (or oenologist).
Ãâó: www.mychefcoat.com/terms-e.html
enology The science and technical study of winemaking.
Ãâó: www.marylandwine.com/wineries/appreciation/glossar...
enology The science and study of wine and winemaking. Also spelled oenology.
Ãâó: www.valleyvineyards.com/wine_glossary_def.htm
enophthalmus Unter einem Enophthalmus (Ophthalmos, griech.: ???Augapfel? versteht man das Einsinken des Augapfels in die Augenh?le (Orbita). Es handelt sich hierbei um ein Symptom, das vielf?tige Ursachen haben kann: #Sympathikusparalyse: Bei einer Sch?igung des Kopfteils des Sympathikus f?lt unter anderem der Musculus orbitalis (glatte Muskulatur in der Periorbita) aus. ...
Ãâó: de.wikipedia.org/wiki/Enophthalmus
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
ENO enough to meet a purpose
ENO as much as necessary
ENO speak, pronounce, or utter in a certain way
ENO trade name for an oral contraceptive containing mestranol and norethynodrel
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á